BIOCRYST PHARMACEUTICALS, INC. Trademark

Trademark Overview

On Tuesday, August 14, 2007, a trademark application was filed for BIOCRYST PHARMACEUTICALS, INC. with the United States Patent and Trademark Office. The USPTO has given the BIOCRYST PHARMACEUTICALS, INC. trademark a serial number of 77254489. The federal status of this trademark filing is REGISTERED AND RENEWED as of Monday, April 4, 2022. This trademark is owned by BioCryst Pharmaceuticals, Inc.. The BIOCRYST PHARMACEUTICALS, INC. trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Pharmaceutical research and drug development; medical and scientific research, namely, conducting clinical trials; development of pharmaceuticals for the treatment of infectious, viral, inflammatory, immunological and autoimmune diseases and disorders; development of pharmaceuticals for the treatment of inflammatory connective tissue diseases; development of pharmaceuticals for the treatment of influenza [ and hepatitis ] ; development of pharmaceuticals for the treatment of cancer, namely, cancers of the immune system such as T-cell and B-cell leukemias and lymphoma
biocryst pharmaceuticals, inc.

General Information

Serial Number77254489
Word MarkBIOCRYST PHARMACEUTICALS, INC.
Filing DateTuesday, August 14, 2007
Status800 - REGISTERED AND RENEWED
Status DateMonday, April 4, 2022
Registration Number3974836
Registration DateTuesday, June 7, 2011
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, January 1, 2008

Trademark Statements

Disclaimer with Predetermined Text"PHARMACEUTICALS, INC."
Goods and ServicesPharmaceutical research and drug development; medical and scientific research, namely, conducting clinical trials; development of pharmaceuticals for the treatment of infectious, viral, inflammatory, immunological and autoimmune diseases and disorders; development of pharmaceuticals for the treatment of inflammatory connective tissue diseases; development of pharmaceuticals for the treatment of influenza [ and hepatitis ] ; development of pharmaceuticals for the treatment of cancer, namely, cancers of the immune system such as T-cell and B-cell leukemias and lymphoma

Classification Information

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateFriday, August 17, 2007
Primary Code042
First Use Anywhere DateTuesday, August 14, 2007
First Use In Commerce DateTuesday, August 14, 2007

Trademark Owner History

Party NameBioCryst Pharmaceuticals, Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressDurham, NC 27703
Party NameBioCryst Pharmaceuticals, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressDurham, NC 27703
Party NameBioCryst Pharmaceuticals, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressBirmingham, AL 352441879

Trademark Events

Event DateEvent Description
Wednesday, May 3, 2023ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
Monday, April 4, 2022NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
Monday, April 4, 2022REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
Monday, April 4, 2022REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
Monday, April 4, 2022CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Monday, December 6, 2021TEAS SECTION 8 & 9 RECEIVED
Wednesday, July 21, 2021TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, July 21, 2021ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Wednesday, July 21, 2021TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Thursday, May 6, 2021TEAS CHANGE OF CORRESPONDENCE RECEIVED
Thursday, May 6, 2021ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, May 6, 2021TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Friday, April 16, 2021APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Friday, April 16, 2021TEAS CHANGE OF CORRESPONDENCE RECEIVED
Friday, April 16, 2021ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Friday, April 16, 2021TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Friday, April 16, 2021TEAS CHANGE OF OWNER ADDRESS RECEIVED
Sunday, June 7, 2020COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
Thursday, July 12, 2018TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, August 1, 2017NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
Tuesday, August 1, 2017REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Monday, July 31, 2017CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Thursday, June 15, 2017TEAS SECTION 8 & 15 RECEIVED
Tuesday, June 7, 2011REGISTERED-PRINCIPAL REGISTER
Wednesday, May 4, 2011NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Tuesday, May 3, 2011LAW OFFICE REGISTRATION REVIEW COMPLETED
Saturday, April 30, 2011ASSIGNED TO LIE
Thursday, April 14, 2011ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Friday, March 25, 2011STATEMENT OF USE PROCESSING COMPLETE
Wednesday, March 23, 2011USE AMENDMENT FILED
Wednesday, March 23, 2011TEAS STATEMENT OF USE RECEIVED
Tuesday, September 28, 2010NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, September 27, 2010SOU EXTENSION 5 GRANTED
Wednesday, September 22, 2010SOU EXTENSION 5 FILED
Wednesday, September 22, 2010TEAS EXTENSION RECEIVED
Thursday, May 6, 2010NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, May 5, 2010SOU EXTENSION 4 GRANTED
Thursday, March 25, 2010SOU EXTENSION 4 FILED
Tuesday, May 4, 2010EXTENSION RECEIVED WITH TEAS PETITION
Tuesday, May 4, 2010PETITION TO REVIVE-GRANTED
Tuesday, May 4, 2010TEAS PETITION TO REVIVE RECEIVED
Monday, April 26, 2010ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
Monday, April 26, 2010ABANDONMENT - NO USE STATEMENT FILED
Tuesday, September 29, 2009SOU EXTENSION 3 GRANTED
Thursday, September 24, 2009SOU EXTENSION 3 FILED
Thursday, September 24, 2009TEAS EXTENSION RECEIVED
Wednesday, April 8, 2009SOU EXTENSION 2 GRANTED
Tuesday, March 24, 2009SOU EXTENSION 2 FILED
Wednesday, April 8, 2009CASE ASSIGNED TO INTENT TO USE PARALEGAL
Tuesday, March 24, 2009TEAS EXTENSION RECEIVED
Thursday, September 25, 2008SOU EXTENSION 1 GRANTED
Thursday, September 25, 2008SOU EXTENSION 1 FILED
Thursday, September 25, 2008TEAS EXTENSION RECEIVED
Tuesday, March 25, 2008NOA MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, January 1, 2008PUBLISHED FOR OPPOSITION
Wednesday, December 12, 2007NOTICE OF PUBLICATION
Wednesday, November 28, 2007LAW OFFICE PUBLICATION REVIEW COMPLETED
Friday, November 23, 2007APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, November 23, 2007EXAMINER'S AMENDMENT ENTERED
Friday, November 23, 2007ASSIGNED TO LIE
Friday, November 23, 2007NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Friday, November 23, 2007EXAMINERS AMENDMENT E-MAILED
Friday, November 23, 2007EXAMINERS AMENDMENT -WRITTEN
Wednesday, November 21, 2007ASSIGNED TO EXAMINER
Friday, August 17, 2007NEW APPLICATION ENTERED

Related Keywords

pharmaceuticals biocryst development treatment inflammatory namely cell diseases research tissue hepatitis